1. Malignant hyperthermia: is your facility prepared to treat this rare condition? Publication: [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008 Subject(s): Dantrolene -- therapeutic useMalignant Hyperthermia -- therapyMuscle Relaxants, Central -- therapeutic useAnesthesia -- adverse effectsAnesthetics, Inhalation -- adverse effectsMalignant Hyperthermia -- diagnosisMalignant Hyperthermia -- prevention & controlRisk FactorsHumansPennsylvaniaUnited States
